exagen-logo-black.png
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 13, 2024 16:05 ET | Exagen Inc.
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following...
RevolutionLogo.png
Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
May 24, 2023 16:05 ET | Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today...
ConduentLogo_400x400px.jpg
Conduent to Attend TD Cowen’s 51st Annual Technology, Media and Telecom Conference
May 24, 2023 12:59 ET | Conduent Business Services, LLC
FLORHAM PARK, N.J., May 24, 2023 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today announced that it is scheduled to...